EXACT SCIENCES CORP (EXAS)
US30063P1057 - Common Stock
Exact Sciences to Participate in June Investor Conferences
Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns
We're heading into our third year of this raging bull market, and there doesn't appear to be any end in sight for these high-return stocks.
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
The companies are likely to soon battle it out in the colon cancer screening market.
Stay updated with the stocks that are on the move in today's after-hours session.
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Oversold Conditions For EXACT Sciences (EXAS)
Exact Sciences Earns 2024 Great Place To Work® Certification™
Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
Discover three biotech stocks handpicked by Cathie Wood, offering groundbreaking therapies and substantial growth potential.
Noteworthy Thursday Option Activity: RCM, EXAS, UPS
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday!
Exact Sciences (EXAS) Q1 2024 Earnings Call Transcript
EXAS earnings call for the period ending March 31, 2024.
EXAS Stock Earnings: Exact Sciences Misses EPS, Beats Revenue for Q1 2024
EXAS stock results show that Exact Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses
The company reported better-than-expected sales, but losses widened and missed forecasts.
Exact Sciences Announces First-Quarter 2024 Results
Exact Sciences to Participate in May Investor Conference
Notable Tuesday Option Activity: X, SPHR, EXAS
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
Exact Sciences Schedules First Quarter 2024 Earnings Call
The 3 Best Cathie Wood Stocks to Buy in April 2024
Cathie Wood doesn't have a great overall record, but she sometimes makes great picks. Here are the three best Cathie Wood stocks to buy now.
The 3 Best Cathie Wood Stocks to Buy in April 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Full disclosure, I’m not a tremendous fan of Cathie Wood. Generally, I th...
1 Beaten-Down Cathie Wood Stock to Buy and Hold
This company is innovating where it matters most, which could prove highly lucrative down the road.
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
The companies are working to detect colon cancer and precancerous markers in blood and/or stool.